Records containing: Hyperlipidemia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-10-22A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 145 in Subjects With Hyperlipidemia on Stable Doses of a Statin
-
CLINICAL_TRIALS study record update · 2015-10-08An Intervention to Improve Medication Knowledge & Compliance Among Family Practice Patients in South Texas: An RRNEST Study.
-
CLINICAL_TRIALS study record update · 2015-10-05A Randomized, Placebo- and Ezetimibe-controlled, Dose-ranging Study to Evaluate Tolerability and Efficacy of AMG 145 on LDL-C in Hypercholesterolemic Subjects With a 10-year Framingham Risk Score of 10% or Less
-
CLINICAL_TRIALS study record update · 2015-10-01LAPLACE TIMI 57 - A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose-ranging Study to Evaluate Tolerability and Efficacy of AMG 145 on LDL-C in Combination With HMG-CoA Reductase Inhibitors in Hypercholesterolemic Subjects
-
CLINICAL_TRIALS study record update · 2015-09-25Telephone Based Management of Hyperlipidemia Utilizing a Self Monitoring Testing Device
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-09-23A Phase 3, Randomized, Double- Blind, Multi-center, Double Dummy, Clinical Trial Comparing HL-040XC With Single Component Therapies(Atorvastatin, Losartan) to Assess the Efficacy and Safety of HL-040XC in Patients With Essential Hypertension and Hyperlipidemia
-
CLINICAL_TRIALS study record update · 2015-08-21Does Step Count Feedback Enhance Counseling for Weight Loss?
-
CLINICAL_TRIALS study record update · 2015-07-23Gender Dependent Difference in Postprandial Lipemia and Glucose Responses After Six Different Fat Tolerance Tests in Young Healthy Subjects
-
CLINICAL_TRIALS study record update · 2015-07-07ClinicalTrials.gov study NCT02280590
-
CLINICAL_TRIALS study record update · 2015-06-12Multicenter Randomized Double-Blind Placebo and Active Comparator Controlled Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of MBX-8025 in Moderately Obese Hyperlipidemic Patients With/Out Concomitant Atorvastatin"
-
CLINICAL_TRIALS study record update · 2015-05-15A Prospective, Double Blind, Placebo-Controlled, Randomized, Multicentric, Study to Evaluate the Safety, Efficacy and Tolerability of PreLipid®, a Twice-daily Nutritional Supplement in Subjects With Higher Than Normal Blood Lipid Levels
-
CLINICAL_TRIALS study record update · 2015-05-13Physiology and Pathologic Role of Endothelium-Derived Hyperpolarizing Factor in Humans
-
CLINICAL_TRIALS study record update · 2015-04-22Phase 3 Multi-Center, Double-Blind, Randomized, Parallel Group, Carotid B-Mode Ultrasound Evaluation of the Anti-Atherosclerotic Efficacy, Safety and Tolerability of Fixed Combination CP-529,414/Atorvastatin, Administered Orally, Once Daily (QD) for 24 Months, Compared With Maximally Tolerated Atorvastatin Therapy Alone, in Subjects With Heterozygous Familial Hypercholesterolemia.
-
CLINICAL_TRIALS study record update · 2015-04-22A Pilot Study on the Effect of Vitamin D Treatment in Patients With Statin-Associated Myalgia
-
CLINICAL_TRIALS study record update · 2015-04-07Community Based Multiple Risk Factors Intervention Strategy to Prevent Cardiovascular and Chronic Kidney Diseases [CORFIS]
-
CLINICAL_TRIALS study record update · 2015-03-24Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Patients With Mixed Hyperlipidemia and Two or More Risk Factors to Cardiovascular Disease.
-
CLINICAL_TRIALS study record update · 2015-03-12A Randomized, Double-Blind, 3-Period Crossover Study to Evaluate the Effects of a Dietary Supplement Containing Botanical Extracts on Fasting and Postprandial Lipid Metabolism in Apparently Healthy, Overweight and Obese Individuals
-
CLINICAL_TRIALS study record update · 2015-03-10Regulation of Intestinal and Hepatic Lipoprotein Production by Glucose and Fructose
-
CLINICAL_TRIALS study record update · 2015-02-25ClinicalTrials.gov study NCT00565292
-
CLINICAL_TRIALS study record update · 2015-02-02Financial Incentives for Medication Adherence
-
CLINICAL_TRIALS study record update · 2014-12-15A Multicenter, Randomized, Factorial, Double-blinded, Double-dummy Phase Ⅲ Trial to Evaluate the Efficacy and Safety of the Coadministration of Valsartan 160mg and Rosuvastatin 20mg in Comparison to Each Component Administered Alone in Patients With Hypertension and Hyperlipidemia
-
CLINICAL_TRIALS study record update · 2014-12-02Baseline Physiology Studies in Carriers of Gene Variant X Conferring Major Risk of CVD-prone Metabolic Disorders
-
CLINICAL_TRIALS study record update · 2014-11-24Comparison of LDL-P With LDLC From VAPII, NMR, and Ion Mobility
-
CLINICAL_TRIALS study record update · 2014-11-21Effect of Cheese on Cardiovascular Risk
-
CLINICAL_TRIALS study record update · 2014-10-30Diabetic Under 70 (Diabetics Below 70)